Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma

Lara E. Davis, Vanessa Bolejack, Christopher W. Ryan, Kristen N. Ganjoo, Elizabeth T. Loggers, Sant Chawla, Mark Agulnik, Michael B. Livingston, Damon Reed, Vicky Keedy, Daniel Rushing, Scott Okuno, Denise K. Reinke, Richard F. Riedel, Steven Attia, Leo Mascarenhas, Robert G. Maki

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences